Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profileg
Dana-Farber’s Breast Oncology Center

@DFCI_BreastOnc

Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425

ID:1491159909794291720

linkhttps://www.dana-farber.org/breast-oncology-program/ calendar_today08-02-2022 21:20:39

4,1K Tweets

4,5K Followers

338 Following

Follow People
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

Could Aspirin Help Treat Breast Cancer?
Lead author, Wendy Y. Chen, MD, recently discussed her study results with MDedge, learn more here:
mdedge.com/hematology-onc…

account_circle
Dana-Farber News(@DanaFarberNews) 's Twitter Profile Photo

Beloved radio host Candy O'Terry aka Candy O recently chronicled her breast diagnosis, treatment and survivorship journey. Read about her moving experience in Pink Chair Storytellers:

➡️ ms.spr.ly/6018YpRVE

account_circle
Dana-Farber(@DanaFarber) 's Twitter Profile Photo

Join us in-person or virtually on 6/5 from 2–3:15 pm for the Helen Gurley Brown Presidential Summit on Women and Science. Hear from prominent leaders in science, celebrate & support women in research and medicine, and engage in a dynamic Q&A session.

jimmyfund.gives/zme94ork

Join us in-person or virtually on 6/5 from 2–3:15 pm for the Helen Gurley Brown Presidential Summit on Women and Science. Hear from prominent leaders in science, celebrate & support women in research and medicine, and engage in a dynamic Q&A session. jimmyfund.gives/zme94ork
account_circle
VJ Oncology(@VJOncology) 's Twitter Profile Photo

Join us for our Post-ASCO 2024 Highlights 📣🩸

Featuring presentations & panel discussions on selected abstracts from 2024 🔦

Agendas available soon 📝

REGISTER 👉 vjoncology.com/feature/post-a…

24 Sanjay Popat Tom Powles Sara Tolaney Lizzy Smyth

Join us for our Post-ASCO 2024 Highlights 📣🩸 Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦 Agendas available soon 📝 REGISTER 👉 vjoncology.com/feature/post-a… #ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1
account_circle
Polyak Lab(@LabPolyak) 's Twitter Profile Photo

Our study characterizing breast cancer brain metastasis is officially out in PNASNews. We reproted breast cancer-stromal cells interaction induces resistance to HER2-targeting agents via bulky glycoproteins. Congrats to Marie-Anne Goyette and Kornelia Polyak.
pnas.org/doi/abs/10.107…

account_circle
Dana-Farber News(@DanaFarberNews) 's Twitter Profile Photo

The U.S. Preventive Services Task Force now recommends women get biennial mammograms starting at age 40. Dana-Farber's Ann Partridge MD, MPH joined NBC10 Boston to discuss the new guidelines:

ms.spr.ly/6016Yub9e

account_circle
Dana-Farber(@DanaFarber) 's Twitter Profile Photo

Join us 5/18 9a-12p ET for the Ductal Carcinoma In Situ (DCIS) Program virtual patient forum.

This free event features informational presentations about for patients, families, loved ones, and health care professionals.

All are welcome! ms.spr.ly/6019YpziS

Join us 5/18 9a-12p ET for the Ductal Carcinoma In Situ (DCIS) Program virtual patient forum. This free event features informational presentations about #DCIS for patients, families, loved ones, and health care professionals. All are welcome! ms.spr.ly/6019YpziS
account_circle
Dana-Farber(@DanaFarber) 's Twitter Profile Photo

Breast cancer is one of the most common forms of cancer, affecting almost 300,000 women in the United States every year. The good news is that with early detection, the chances of successful treatment are higher.

blog.dana-farber.org/insight/2023/0…

account_circle
Dana-Farber(@DanaFarber) 's Twitter Profile Photo

Join us 5/15 6:30-7:45 pm ET for an interactive virtual social with others who have a loved one living with , part of the EMBRACE Virtual Forum Series.

This is an opportunity to meet, connect, and support one another. ms.spr.ly/6018Ypmwo

Join us 5/15 6:30-7:45 pm ET for an interactive virtual social with others who have a loved one living with #MBC, part of the EMBRACE #MetastaticBreastCancer Virtual Forum Series. This is an opportunity to meet, connect, and support one another. ms.spr.ly/6018Ypmwo
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

We are leading a phase 2 trial, called , to assess if a brief dose escalation of adjuvant w/ ongoing endocrine therapy reduces side effects & improves tolerability in patients with early-stage HR-positive and HER2-negative .
dana-farber.org/clinical-trial…

We are leading a phase 2 trial, called #TRADE, to assess if a brief dose escalation of adjuvant #abemaciclib w/ ongoing endocrine therapy reduces side effects & improves tolerability in patients with early-stage HR-positive and HER2-negative #BreastCancer. dana-farber.org/clinical-trial…
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

For Couples: Virtual Sexual Health Workshop
🗓️May 9 | 7-8:30 pm ET
Dr. Bober (Sharon L Bober) will address common changes that may affect couples after a diagnosis and provide ways to improve communication.
redcap.partners.org/redcap/surveys…

For Couples: Virtual Sexual Health Workshop 🗓️May 9 | 7-8:30 pm ET Dr. Bober (@DrSharonBober) will address common changes that may affect couples after a #breastcancer diagnosis and provide ways to improve communication. redcap.partners.org/redcap/surveys…
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

Learn about the design and implementation of an opt-out, end-to-end, preemptive DPYD testing program for patients planned for a systemic fluoropyrimidine in this recent JCO Oncology Practice publication.
Craig Bunnell, MD Doug Rubinson
👉pubmed.ncbi.nlm.nih.gov/38608224/

Learn about the design and implementation of an opt-out, end-to-end, preemptive DPYD testing program for patients planned for a systemic fluoropyrimidine in this recent @JCOOP_ASCO publication. @bunnell_craig #CarolineBlock @Labrat3 👉pubmed.ncbi.nlm.nih.gov/38608224/
account_circle
UTSW Simmons Cancer Center(@utswcancer) 's Twitter Profile Photo

Thank you to all who attended the 2024 Reves International Breast Cancer Symposium and a special thanks to the amazing speakers for bringing forward their insightful work as we all collaborate to end breast cancer. Carlos L. Arteaga, M.D. Debb Farr Heather McArthur, MD, MPH

Thank you to all who attended the 2024 Reves International Breast Cancer Symposium and a special thanks to the amazing speakers for bringing forward their insightful work as we all collaborate to end breast cancer. @CarlosArteagaMD @DVFelaine @hmcarthur
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

Kate Santos, one of our rising💫Clinical Research Coordinators, currently working in Heather Parsons' lab, visited Bunker Hill Community College to speak with students about her current role and to discuss careers in oncology and research.

Kate Santos, one of our rising💫Clinical Research Coordinators, currently working in @hthrparsons' lab, visited Bunker Hill Community College to speak with #STEM students about her current role and to discuss careers in oncology and research. #PeerToPeerEducation #womeninSTEM
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

Check out our newest treatment guideline on the use of low-dose tamoxifen in patients with estrogen receptor-positive (ER+) ductal carcinoma in situ
Brittany Bychkovsky, MD Tari King MD Dr. E Mittendorf
👇👇
physicianresources.dana-farber.org/flexpaper/trea…

Check out our newest treatment guideline on the use of low-dose tamoxifen in patients with estrogen receptor-positive (ER+) ductal carcinoma in situ #DCIS #BOCGuideline #CancerGuideline #DuctalCarcinomaInSitu @DrBBychkovsky @TariKingMD @EMittendorfMD 👇👇 physicianresources.dana-farber.org/flexpaper/trea…
account_circle